144 related articles for article (PubMed ID: 3126739)
21. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.
Trepel JB; Colamonici OR; Kelly K; Schwab G; Watt RA; Sausville EA; Jaffe ES; Neckers LM
Mol Cell Biol; 1987 Jul; 7(7):2644-8. PubMed ID: 3039354
[TBL] [Abstract][Full Text] [Related]
22. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.
Holt JT; Redner RL; Nienhuis AW
Mol Cell Biol; 1988 Feb; 8(2):963-73. PubMed ID: 3280975
[TBL] [Abstract][Full Text] [Related]
23. Activation of protein kinase C enhances TNF-alpha-induced differentiation by preventing apoptosis via rapid up-regulation of c-Myc protein expression in HL-60 cells.
Kumakura S; Ishikura H; Maniwa Y; Munemasa S; Tsumura H; Masuda J; Kobayashi S
Leuk Lymphoma; 2003 Mar; 44(3):497-503. PubMed ID: 12688321
[TBL] [Abstract][Full Text] [Related]
24. Suppression of c-myc and c-myb expression in myeloid cell lines treated with recombinant tumor necrosis factor-alpha.
Schachner J; Blick M; Freireich E; Gutterman J; Beran M
Leukemia; 1988 Nov; 2(11):749-53. PubMed ID: 3054350
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Carlo-Stella C; Cazzola M; De Fazio P; Pedrazzoli P; Peverali FA; Della Valle G
Leukemia; 1990 Jun; 4(6):426-30. PubMed ID: 2359342
[TBL] [Abstract][Full Text] [Related]
26. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
Marshall AH; Alper D; Hiscott J
J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
[TBL] [Abstract][Full Text] [Related]
27. Cooperative effects of tumor necrosis factor-alpha and 1,25-dihydroxyvitamin D3 on growth inhibition, differentiation, and c-myc reduction in human promyelocytic leukemia cell line HL-60.
Katakami Y; Nakao Y; Katakami N; Koizumi T; Ogawa R; Yamada H; Takai Y; Fujita T
Biochem Biophys Res Commun; 1988 May; 152(3):1151-7. PubMed ID: 3163919
[TBL] [Abstract][Full Text] [Related]
28. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
29. Physiological cyclic AMP stimulation and oncogene mRNA levels in HL-60 cells.
Moens U; Bang BE; Aarbakke J
Life Sci; 1990; 47(17):1555-60. PubMed ID: 2174489
[TBL] [Abstract][Full Text] [Related]
30. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
31. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
Coppola JA; Parker JM; Schuler GD; Cole MD
Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
[TBL] [Abstract][Full Text] [Related]
32. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
Boise LH; Gorse KM; Westin EH
Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
[TBL] [Abstract][Full Text] [Related]
33. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
Friedrich B; Gullberg M; Lundgren E
Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
[TBL] [Abstract][Full Text] [Related]
34. Relationships between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation.
Barker KA; Newburger PE
Exp Cell Res; 1990 Jan; 186(1):1-5. PubMed ID: 2404770
[TBL] [Abstract][Full Text] [Related]
35. Cooperative regulation of c-myc expression in differentiation of human promyelocytic leukemia induced by recombinant gamma-interferon and 1,25-dihydroxyvitamin D3.
Matsui T; Takahashi R; Mihara K; Nakagawa T; Koizumi T; Nakao Y; Sugiyama T; Fujita T
Cancer Res; 1985 Sep; 45(9):4366-71. PubMed ID: 3928155
[TBL] [Abstract][Full Text] [Related]
36. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
37. Proto-oncogene expression in HL-60 cells exposed to ara-C.
Sato H; Preisler HD
Semin Oncol; 1987 Jun; 14(2 Suppl 1):192-201. PubMed ID: 3296204
[TBL] [Abstract][Full Text] [Related]
38. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
Wickstrom EL; Bacon TA; Gonzalez A; Freeman DL; Lyman GH; Wickstrom E
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1028-32. PubMed ID: 3277186
[TBL] [Abstract][Full Text] [Related]
39. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
